Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs Propofol for TAVR Anesthesia
NCT05035069Phase 4Unknown
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2021
- Primary completion
- Feb 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ciprofol in general anesthesia (2 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoint: Percentage of time that BIS value is maintained between 40 and 60 at Day 1. Status: unknown.
02
Drugs
ciprofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05035069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035069.